ScholarIQanswers from OpenAlex

Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions

PaperCitations, authors & open-access status

Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions have?

ScholarIQcitation count

Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions published?

ScholarIQyear

Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions has 2024 year in the ScholarIQ index.

What is the open-access status of Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions?

ScholarIQoa status

Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions has gold oa status in the ScholarIQ index.

What is the DOI of Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions?

ScholarIQdoi

The DOI for Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions is on the source record.

What is the PMID of Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions?

ScholarIQpmid

The PMID for Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions is on the source record.

What is the OpenAlex record for Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions?

ScholarIQopenalex

The OpenAlex for Neighborhood Socioeconomic Disadvantage and 30‐Day Outcomes for Common Cardiovascular Conditions is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial